· Published by Health Canada · Official notice
Health Canada is advising Canadians that Novartis Consumer Health Inc’s U.S. recall is now being extended to Canada. According to Novartis Consumer Health Canada Inc, the Canadian recall includes all lots (expiration dates of December 20, 2014 and earlier) for over-the-counter products, Excedrin Extra Strength Caplets and Excedrin Tension Headache Caplets.
According to the FDA, Novartis Consumer Health Over-The-Counter Products: Recall - Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps and inconsistent bottle packaging clearance practices, which could result in the bottles containing foreign tablets, caplets, or capsules. The U.S. FDA has informed consumers that mixing of different products in the same bottle could result in consumers taking the incorrect product and receiving a higher or lower strength than intended or receiving an unintended ingredient. This could potentially result in overdose, interaction with other medications a consumer may be taking, or an allergic reaction if the consumer is allergic to the unintended ingredient.
Canadians can be confident that Health Canada is monitoring the voluntary recall by Novartis Consumer Health Canada Inc. Should additional information be identified, Health Canada will take appropriate action and inform Canadians.
Health Canada reminds Canadians who have concerns about these products to consult with their health care practitioner. For information concerning the recall or how to return the affected product, consumers should directly contact Novartis Consumer Health Canada Inc’s consumer relationship centre at the following number 1-888-788-8181.